期刊文献+

帕金森病患者血尿酸水平的检测及相关性分析 被引量:1

Assay of uric Acid in the Parkinson's Diseas Patients and Association Analyse
下载PDF
导出
摘要 目的:探讨血尿酸与帕金森病(Parkinson's disease,PD)的关系。方法:选取2006年6月~2010年5月于我院门诊及住院部就诊并诊断为PD的患者46例为PD组,同时选取同期与PD组年龄、性别、民族相匹配的健康体检者46例为对照组,回顾性分析两组受检者空腹肘静脉血尿酸水平,并进行比较。结果:PD组血尿酸水平(273.1±59.3)μmol/L明显低于对照组(307.4±58.8)/μmol/L,(P=0.006)。PD患者Hoehm-Yahr分级Ⅰ~Ⅱ级(283.1±54.5)μmol/L、Ⅲ级(271.9±51.6)μmol/L、Ⅳ~Ⅴ级(260.6±76.7)μmol/L,3组之间血尿酸水平均无显著性差异(P=0.609)。PD患者的血尿酸水平与H—Y分级无明显相关性(r=0.194,P=0.197)。结论:PD患者血尿酸水平降低,低血尿酸水平可能是帕森病的危险因素之一,但不能作为PD患者病情严重程度的判断指标. Objective : To investigate the relationship between serum uric acid and Parkinson's disease. Methods: Totally 46 patients with Parkinson's disease receiving medical service in Yangtse River Ship General Hospital from June 2006 to May 2010 were chosen as experimental group, and 46 healthy persons whose age,sex and ethnic matched the PD patients were erolled as the controls. The fasting serum uric acid level of the two group subjects were retrospectively analyzed and compared. Results: PD group uric acid levels [(273.1± 59.3)μmol/L] were significantly lower than the control group((307.4±58. 8)μmol/L] (P=0. 006). PD patients were divided into three groups,grade Ⅰ - Ⅱ ,Ⅲ and Ⅳ-Ⅴ according to Hoehn-Yahr grade. Serum uric acid levels among the three groups[ Ⅰ - Ⅱ (283. 1±54. 5) μmol / L, Ⅲ (271.9±51.6)μmol / L and Ⅳ -Ⅴ (260. 6±76.7) μmol/L) were not significantly different (P=0. 609). There was no siginificant correlation between uric acid and HY grade level in PD patients. Conclusions. The plasma uric acid in PD patients was lower healthy people. Low level of plasma uric acid is possibly one of the danger factors for PD, but it cafft reflect the severity of PD.
出处 《数理医药学杂志》 2011年第2期159-161,共3页 Journal of Mathematical Medicine
关键词 帕金森病 血尿酸 氧化应激 parkinson's disease uric acid oxdative stress
  • 相关文献

参考文献16

  • 1张振涛,曹学兵,孙圣刚.帕金森病多巴胺神经元死亡的分子机制[J].中国康复,2006,21(6):402-404. 被引量:17
  • 2冯敏,王莎莉.帕金森病发病机理的研究进展[J].国外医学(老年医学分册),2005,26(6):247-251. 被引量:8
  • 3Church WH,Ward VL.Uric acid is reduced in the substantia nigrain Parkinson’’s disease:effect on dopamine oxidation. Brain Research Bulletin . 1994
  • 4Kim TS,Pae CU,Yoon SJ,et al.Decreased plasma antioxidantsin patients with Alzheimer’’s disease. International Journal of Geriatric Psychiatry . 2006
  • 5Pacher P,Beckman JS,Liauder L.Nitric oxide and peroxynitrite in health and disease. Physiological Reviews . 2007
  • 6M Rentzos,C Nikolaou,M Anagnostouli,A Rombos,K Tsakanikas,M Economou,A Dimitrakopoulos,M Karouli,D Vassilopoulos.Serum uric acid and multiple sclerosis. Clinical Neurology and Neurosurgery . 2006
  • 7Duan W.Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’’’’s disease. Journal of Neurochemistry . 2002
  • 8Luo WF,Schwarzschild MA,Xu K.Urate attenuates MPTP-induced dopaminergic toxicity in mice. The Society for neuroscience 37th annual meeting . 2007
  • 9Ballard PA,Tetrud JW,Langston JW.Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology . 1985
  • 10Meara J,Bhowrnick BK,Hobson R.Accuracy of diagnosis in patients with presumed Parkinson’s disease. Age and Ageing . 1999

二级参考文献41

  • 1[1]SPIRA PJ,SHARPE DM,HALLIDAY G,et al.Clinical and Pathological Features of a Parkinsonian Syndrome in a Family with an Ala53Thr Alpha-Synuclein Mutation[J].Ann Neurol(S0364-5134),2001,49(3):313-319.
  • 2[2]SRIRAM SR,LI X,KO HS,et al.Familial-associated Mutations Differentially Disrupt the Solubility,Localization,Binding and Ubiquitination Properties of Parkin[J].Hum Mol Genet(S0964-6906),2005,14(17):2571-2586.
  • 3[3]HEALY DG,ABOU-SLEIMAN PM,WOOD NW.Genetic Causes of Parkinson's Disease:UCHL-1[J].Cell Tissue Res(S0302-766X),2004,318(1):189-194.
  • 4[4]MOMOSE Y,MURATA M,KOBAYASHI K,et al.Association Studies of Multiple Candidate Genes for Parkinson's Disease Using Single Nucleotide Polymorphisms[J].Ann Neurol(S0364-5634),2002,51(1):133-136.
  • 5[5]BONIFATI V,RIZZU P,NANBAREN MJ,et al.Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-onset Parkinsonism[J].Science(S0036-8075),2003,299(5604):256-259.
  • 6[6]SHINBO Y,NIKI T,TAIRA T,et al.Proper SUMO-1 Conjugation is Essential to DJ-1 to Exert Its Full Activities[J].Cell Death Differ(S1350-9087),2006,13(1):96-108.
  • 7[7]GLICKMAN MH,CIECHANOVER A.The Uiquitin-Proteasome Proteolytic Pathway:Destruction for the Sake of Construction[J].Physiol Rev(S0031-9333),2002,82(2):373-428.
  • 8[8]BENCE NF,SAMPAT RM,KOPITO RR.Impairment of the Ubiquitin-proteasome System by Protein Aggregation[J].Science(S0036-8075),2001,292(5521):1552-1555.
  • 9[9]OSTREROVA N,PETRUCELLI L,FARRER M,et al.a-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins[J].J Neurosci(S0270-6474),1999,19(14):5782-5791.
  • 10[10]ROSS CA,PICKART CM.The Ubiquitin-Proteasome Pathway in Parkinson's Disease and Other Neurodegenerative Diseases[J].Trends Cell Biol(S0270-8924),2004,14(12):703-711.

共引文献23

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部